nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—ABCC2—Spironolactone—dilated cardiomyopathy	0.269	0.35	CbGbCtD
Etoposide—ABCC2—Furosemide—dilated cardiomyopathy	0.184	0.239	CbGbCtD
Etoposide—CYP2C8—Spironolactone—dilated cardiomyopathy	0.129	0.168	CbGbCtD
Etoposide—ABCB1—Lisinopril—dilated cardiomyopathy	0.0995	0.129	CbGbCtD
Etoposide—ABCB1—Spironolactone—dilated cardiomyopathy	0.0876	0.114	CbGbCtD
Etoposide—Podofilox—TUBB—dilated cardiomyopathy	0.017	1	CrCbGaD
Etoposide—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.00648	0.0376	CcSEcCtD
Etoposide—Ulcer—Spironolactone—dilated cardiomyopathy	0.00498	0.0288	CcSEcCtD
Etoposide—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00308	0.0178	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00308	0.0178	CcSEcCtD
Etoposide—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00276	0.016	CcSEcCtD
Etoposide—ABCC6—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00276	0.104	CbGpPWpGaD
Etoposide—TOP2A—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.00266	1	CbGdCrCtD
Etoposide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00261	0.0151	CcSEcCtD
Etoposide—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00261	0.0151	CcSEcCtD
Etoposide—Renal failure—Spironolactone—dilated cardiomyopathy	0.00259	0.015	CcSEcCtD
Etoposide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00246	0.0142	CcSEcCtD
Etoposide—ABCC10—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00241	0.0912	CbGpPWpGaD
Etoposide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00224	0.013	CcSEcCtD
Etoposide—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00217	0.0126	CcSEcCtD
Etoposide—Swelling—Furosemide—dilated cardiomyopathy	0.00211	0.0122	CcSEcCtD
Etoposide—Alopecia—Spironolactone—dilated cardiomyopathy	0.00209	0.0121	CcSEcCtD
Etoposide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00198	0.0115	CcSEcCtD
Etoposide—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00192	0.0111	CcSEcCtD
Etoposide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00191	0.0111	CcSEcCtD
Etoposide—Malaise—Spironolactone—dilated cardiomyopathy	0.00186	0.0108	CcSEcCtD
Etoposide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00184	0.0107	CcSEcCtD
Etoposide—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00181	0.0105	CcSEcCtD
Etoposide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00173	0.01	CcSEcCtD
Etoposide—Confusional state—Spironolactone—dilated cardiomyopathy	0.00169	0.00982	CcSEcCtD
Etoposide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00168	0.00973	CcSEcCtD
Etoposide—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00168	0.0097	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00168	0.0097	CcSEcCtD
Etoposide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00165	0.00953	CcSEcCtD
Etoposide—Somnolence—Spironolactone—dilated cardiomyopathy	0.00149	0.00865	CcSEcCtD
Etoposide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00145	0.0084	CcSEcCtD
Etoposide—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00144	0.00835	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00142	0.00823	CcSEcCtD
Etoposide—TOP2B—cardiac ventricle—dilated cardiomyopathy	0.00141	0.115	CbGeAlD
Etoposide—Renal failure—Furosemide—dilated cardiomyopathy	0.00141	0.00816	CcSEcCtD
Etoposide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00138	0.00802	CcSEcCtD
Etoposide—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00136	0.00785	CcSEcCtD
Etoposide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00134	0.00775	CcSEcCtD
Etoposide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00134	0.00773	CcSEcCtD
Etoposide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00133	0.0077	CcSEcCtD
Etoposide—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00133	0.00769	CcSEcCtD
Etoposide—TOP2B—myocardium—dilated cardiomyopathy	0.00133	0.108	CbGeAlD
Etoposide—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00127	0.00736	CcSEcCtD
Etoposide—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00126	0.00731	CcSEcCtD
Etoposide—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00126	0.00728	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00126	0.00728	CcSEcCtD
Etoposide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00124	0.00717	CcSEcCtD
Etoposide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00122	0.00705	CcSEcCtD
Etoposide—Eye disorder—Furosemide—dilated cardiomyopathy	0.0012	0.00697	CcSEcCtD
Etoposide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00119	0.00689	CcSEcCtD
Etoposide—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00119	0.00687	CcSEcCtD
Etoposide—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00118	0.00681	CcSEcCtD
Etoposide—Angiopathy—Furosemide—dilated cardiomyopathy	0.00117	0.00676	CcSEcCtD
Etoposide—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00116	0.00673	CcSEcCtD
Etoposide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00115	0.00666	CcSEcCtD
Etoposide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00115	0.00664	CcSEcCtD
Etoposide—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00113	0.00653	CcSEcCtD
Etoposide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00111	0.00644	CcSEcCtD
Etoposide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0011	0.00635	CcSEcCtD
Etoposide—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00108	0.00627	CcSEcCtD
Etoposide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00108	0.00624	CcSEcCtD
Etoposide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00107	0.00619	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00107	0.00618	CcSEcCtD
Etoposide—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00106	0.00614	CcSEcCtD
Etoposide—Rash—Spironolactone—dilated cardiomyopathy	0.00106	0.00614	CcSEcCtD
Etoposide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00106	0.00613	CcSEcCtD
Etoposide—Renal failure—Lisinopril—dilated cardiomyopathy	0.00106	0.00612	CcSEcCtD
Etoposide—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00105	0.00611	CcSEcCtD
Etoposide—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00105	0.00611	CcSEcCtD
Etoposide—Headache—Spironolactone—dilated cardiomyopathy	0.00105	0.0061	CcSEcCtD
Etoposide—Jaundice—Lisinopril—dilated cardiomyopathy	0.00105	0.00607	CcSEcCtD
Etoposide—Anaemia—Furosemide—dilated cardiomyopathy	0.00104	0.006	CcSEcCtD
Etoposide—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00102	0.00589	CcSEcCtD
Etoposide—Vertigo—Furosemide—dilated cardiomyopathy	0.00101	0.00583	CcSEcCtD
Etoposide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.001	0.00581	CcSEcCtD
Etoposide—Leukopenia—Furosemide—dilated cardiomyopathy	0.001	0.00581	CcSEcCtD
Etoposide—Nausea—Spironolactone—dilated cardiomyopathy	0.000998	0.00578	CcSEcCtD
Etoposide—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000954	0.00552	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000947	0.00549	CcSEcCtD
Etoposide—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000947	0.00548	CcSEcCtD
Etoposide—ABCC3—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000934	0.0353	CbGpPWpGaD
Etoposide—TOP2B—heart—dilated cardiomyopathy	0.000926	0.0756	CbGeAlD
Etoposide—Confusional state—Furosemide—dilated cardiomyopathy	0.000922	0.00534	CcSEcCtD
Etoposide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000914	0.0053	CcSEcCtD
Etoposide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000913	0.00529	CcSEcCtD
Etoposide—Flushing—Lisinopril—dilated cardiomyopathy	0.000896	0.00519	CcSEcCtD
Etoposide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000895	0.00519	CcSEcCtD
Etoposide—Skin disorder—Furosemide—dilated cardiomyopathy	0.000888	0.00514	CcSEcCtD
Etoposide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000884	0.00512	CcSEcCtD
Etoposide—GSTP1—cardiac ventricle—dilated cardiomyopathy	0.000884	0.0721	CbGeAlD
Etoposide—ABCC10—cardiac ventricle—dilated cardiomyopathy	0.000883	0.072	CbGeAlD
Etoposide—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000876	0.00507	CcSEcCtD
Etoposide—Anorexia—Furosemide—dilated cardiomyopathy	0.000872	0.00505	CcSEcCtD
Etoposide—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00087	0.00504	CcSEcCtD
Etoposide—Chills—Lisinopril—dilated cardiomyopathy	0.000866	0.00502	CcSEcCtD
Etoposide—Hypotension—Furosemide—dilated cardiomyopathy	0.000854	0.00495	CcSEcCtD
Etoposide—Alopecia—Lisinopril—dilated cardiomyopathy	0.000853	0.00494	CcSEcCtD
Etoposide—GSTP1—myocardium—dilated cardiomyopathy	0.000831	0.0678	CbGeAlD
Etoposide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000823	0.00477	CcSEcCtD
Etoposide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000821	0.00476	CcSEcCtD
Etoposide—Back pain—Lisinopril—dilated cardiomyopathy	0.000813	0.00471	CcSEcCtD
Etoposide—Somnolence—Furosemide—dilated cardiomyopathy	0.000813	0.00471	CcSEcCtD
Etoposide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000808	0.00468	CcSEcCtD
Etoposide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000795	0.0046	CcSEcCtD
Etoposide—TOP2B—cardiac atrium—dilated cardiomyopathy	0.000792	0.0646	CbGeAlD
Etoposide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000789	0.00457	CcSEcCtD
Etoposide—Fatigue—Furosemide—dilated cardiomyopathy	0.000788	0.00457	CcSEcCtD
Etoposide—Pain—Furosemide—dilated cardiomyopathy	0.000782	0.00453	CcSEcCtD
Etoposide—Constipation—Furosemide—dilated cardiomyopathy	0.000782	0.00453	CcSEcCtD
Etoposide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00078	0.00452	CcSEcCtD
Etoposide—Anaemia—Lisinopril—dilated cardiomyopathy	0.000777	0.0045	CcSEcCtD
Etoposide—Malaise—Lisinopril—dilated cardiomyopathy	0.000758	0.00439	CcSEcCtD
Etoposide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000755	0.00437	CcSEcCtD
Etoposide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000753	0.00436	CcSEcCtD
Etoposide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000752	0.00436	CcSEcCtD
Etoposide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000748	0.00433	CcSEcCtD
Etoposide—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00074	0.028	CbGpPWpGaD
Etoposide—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000739	0.00428	CcSEcCtD
Etoposide—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.000738	0.0279	CbGpPWpGaD
Etoposide—Cough—Lisinopril—dilated cardiomyopathy	0.000733	0.00425	CcSEcCtD
Etoposide—ABCC1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000732	0.0277	CbGpPWpGaD
Etoposide—Urticaria—Furosemide—dilated cardiomyopathy	0.000726	0.00421	CcSEcCtD
Etoposide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000723	0.00419	CcSEcCtD
Etoposide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000723	0.00419	CcSEcCtD
Etoposide—Chest pain—Lisinopril—dilated cardiomyopathy	0.000716	0.00415	CcSEcCtD
Etoposide—GSTP1—Detoxification of Reactive Oxygen Species—SOD2—dilated cardiomyopathy	0.000715	0.027	CbGpPWpGaD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000711	0.00412	CcSEcCtD
Etoposide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000707	0.0041	CcSEcCtD
Etoposide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000692	0.00401	CcSEcCtD
Etoposide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000686	0.00397	CcSEcCtD
Etoposide—GSTP1—Detoxification of Reactive Oxygen Species—GPX1—dilated cardiomyopathy	0.000682	0.0258	CbGpPWpGaD
Etoposide—Infection—Lisinopril—dilated cardiomyopathy	0.000682	0.00395	CcSEcCtD
Etoposide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000674	0.0039	CcSEcCtD
Etoposide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000672	0.00389	CcSEcCtD
Etoposide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00067	0.00388	CcSEcCtD
Etoposide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000666	0.00386	CcSEcCtD
Etoposide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000663	0.00384	CcSEcCtD
Etoposide—Asthenia—Furosemide—dilated cardiomyopathy	0.000656	0.0038	CcSEcCtD
Etoposide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000654	0.00379	CcSEcCtD
Etoposide—Pruritus—Furosemide—dilated cardiomyopathy	0.000647	0.00375	CcSEcCtD
Etoposide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000641	0.00371	CcSEcCtD
Etoposide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000626	0.00362	CcSEcCtD
Etoposide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000616	0.00357	CcSEcCtD
Etoposide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000612	0.00354	CcSEcCtD
Etoposide—Somnolence—Lisinopril—dilated cardiomyopathy	0.00061	0.00353	CcSEcCtD
Etoposide—Dizziness—Furosemide—dilated cardiomyopathy	0.000605	0.0035	CcSEcCtD
Etoposide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000596	0.00345	CcSEcCtD
Etoposide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000592	0.00343	CcSEcCtD
Etoposide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000591	0.00343	CcSEcCtD
Etoposide—ABCC1—myocardium—dilated cardiomyopathy	0.000588	0.0479	CbGeAlD
Etoposide—Constipation—Lisinopril—dilated cardiomyopathy	0.000587	0.0034	CcSEcCtD
Etoposide—Pain—Lisinopril—dilated cardiomyopathy	0.000587	0.0034	CcSEcCtD
Etoposide—Vomiting—Furosemide—dilated cardiomyopathy	0.000581	0.00337	CcSEcCtD
Etoposide—GSTP1—heart—dilated cardiomyopathy	0.00058	0.0473	CbGeAlD
Etoposide—ABCC10—heart—dilated cardiomyopathy	0.00058	0.0473	CbGeAlD
Etoposide—Rash—Furosemide—dilated cardiomyopathy	0.000576	0.00334	CcSEcCtD
Etoposide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000576	0.00334	CcSEcCtD
Etoposide—Headache—Furosemide—dilated cardiomyopathy	0.000573	0.00332	CcSEcCtD
Etoposide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000565	0.00327	CcSEcCtD
Etoposide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000561	0.00325	CcSEcCtD
Etoposide—TOP2A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.000547	0.0207	CbGpPWpGaD
Etoposide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000545	0.00316	CcSEcCtD
Etoposide—Nausea—Furosemide—dilated cardiomyopathy	0.000543	0.00315	CcSEcCtD
Etoposide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000542	0.00314	CcSEcCtD
Etoposide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000542	0.00314	CcSEcCtD
Etoposide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000505	0.00293	CcSEcCtD
Etoposide—GSTP1—cardiac atrium—dilated cardiomyopathy	0.000496	0.0405	CbGeAlD
Etoposide—ABCC10—cardiac atrium—dilated cardiomyopathy	0.000496	0.0404	CbGeAlD
Etoposide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000492	0.00285	CcSEcCtD
Etoposide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000485	0.00281	CcSEcCtD
Etoposide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000469	0.00272	CcSEcCtD
Etoposide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000454	0.00263	CcSEcCtD
Etoposide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000436	0.00253	CcSEcCtD
Etoposide—Rash—Lisinopril—dilated cardiomyopathy	0.000433	0.00251	CcSEcCtD
Etoposide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000432	0.0025	CcSEcCtD
Etoposide—Headache—Lisinopril—dilated cardiomyopathy	0.00043	0.00249	CcSEcCtD
Etoposide—ABCC1—heart—dilated cardiomyopathy	0.00041	0.0335	CbGeAlD
Etoposide—Nausea—Lisinopril—dilated cardiomyopathy	0.000407	0.00236	CcSEcCtD
Etoposide—PTGS1—myocardium—dilated cardiomyopathy	0.000406	0.0331	CbGeAlD
Etoposide—ABCC1—S1P1 pathway—RAC1—dilated cardiomyopathy	0.000401	0.0152	CbGpPWpGaD
Etoposide—ABCC1—cardiac atrium—dilated cardiomyopathy	0.000351	0.0286	CbGeAlD
Etoposide—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000348	0.0132	CbGpPWpGaD
Etoposide—ABCG2—heart—dilated cardiomyopathy	0.00034	0.0277	CbGeAlD
Etoposide—ABCC6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000319	0.0121	CbGpPWpGaD
Etoposide—ABCC6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00031	0.0117	CbGpPWpGaD
Etoposide—ABCC6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00031	0.0117	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000299	0.0113	CbGpPWpGaD
Etoposide—ABCC6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000288	0.0109	CbGpPWpGaD
Etoposide—PTGS1—heart—dilated cardiomyopathy	0.000283	0.0231	CbGeAlD
Etoposide—ABCC10—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000279	0.0105	CbGpPWpGaD
Etoposide—ABCC10—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000271	0.0103	CbGpPWpGaD
Etoposide—ABCC10—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000271	0.0103	CbGpPWpGaD
Etoposide—PTGS2—heart—dilated cardiomyopathy	0.000271	0.0221	CbGeAlD
Etoposide—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.000269	0.0102	CbGpPWpGaD
Etoposide—ABCC10—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000252	0.00953	CbGpPWpGaD
Etoposide—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000242	0.0198	CbGeAlD
Etoposide—GSTT1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00021	0.00793	CbGpPWpGaD
Etoposide—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.000203	0.00769	CbGpPWpGaD
Etoposide—ABCC1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000202	0.00763	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—TAZ—dilated cardiomyopathy	0.000197	0.00745	CbGpPWpGaD
Etoposide—TOP2A—Gastric Cancer Network 2—EGFR—dilated cardiomyopathy	0.000178	0.00674	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—SDHA—dilated cardiomyopathy	0.000178	0.00674	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.000178	0.00672	CbGpPWpGaD
Etoposide—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000173	0.00654	CbGpPWpGaD
Etoposide—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00017	0.00645	CbGpPWpGaD
Etoposide—ABCB1—heart—dilated cardiomyopathy	0.000167	0.0137	CbGeAlD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000159	0.00603	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TUBB—dilated cardiomyopathy	0.000159	0.00601	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000158	0.00599	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00015	0.00566	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000149	0.00563	CbGpPWpGaD
Etoposide—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000147	0.00556	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—EMD—dilated cardiomyopathy	0.000142	0.00536	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000141	0.00533	CbGpPWpGaD
Etoposide—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.00014	0.0053	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000139	0.00526	CbGpPWpGaD
Etoposide—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000135	0.00512	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000133	0.00504	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.000131	0.00497	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000125	0.00472	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000117	0.00444	CbGpPWpGaD
Etoposide—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000117	0.00441	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.000115	0.00436	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000115	0.00434	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—dilated cardiomyopathy	0.000114	0.00431	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000114	0.0043	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00011	0.00417	CbGpPWpGaD
Etoposide—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00011	0.00417	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.00011	0.00416	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000108	0.0041	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—TAZ—dilated cardiomyopathy	0.000108	0.00408	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000108	0.00408	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000105	0.00399	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000105	0.00397	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000105	0.00397	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.92e-05	0.00375	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	9.85e-05	0.00373	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—SDHA—dilated cardiomyopathy	9.76e-05	0.00369	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.76e-05	0.00369	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	9.68e-05	0.00366	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	9.42e-05	0.00356	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	9.33e-05	0.00353	CbGpPWpGaD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	9.33e-05	0.00353	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	9.15e-05	0.00346	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	9.03e-05	0.00341	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	8.96e-05	0.00339	CbGpPWpGaD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	8.88e-05	0.00336	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	8.8e-05	0.00333	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	8.61e-05	0.00326	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.55e-05	0.00324	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.45e-05	0.0032	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TMPO—dilated cardiomyopathy	8.42e-05	0.00319	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.37e-05	0.00317	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.32e-05	0.00315	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.32e-05	0.00315	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	8.29e-05	0.00314	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.22e-05	0.00311	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.22e-05	0.00311	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	8.2e-05	0.0031	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	7.97e-05	0.00302	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.87e-05	0.00298	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.74e-05	0.00293	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	7.73e-05	0.00293	CbGpPWpGaD
Etoposide—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.66e-05	0.0029	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.65e-05	0.00289	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.44e-05	0.00281	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.24e-05	0.00274	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.24e-05	0.00274	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	7.09e-05	0.00268	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	6.95e-05	0.00263	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—LMNA—dilated cardiomyopathy	6.92e-05	0.00262	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.81e-05	0.00258	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.73e-05	0.00255	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	6.67e-05	0.00252	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	6.46e-05	0.00244	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.41e-05	0.00242	CbGpPWpGaD
Etoposide—ABCC6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.29e-05	0.00238	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	6.25e-05	0.00236	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	6.23e-05	0.00236	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.07e-05	0.0023	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	6.04e-05	0.00228	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	6.03e-05	0.00228	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	5.76e-05	0.00218	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.75e-05	0.00218	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	5.56e-05	0.0021	CbGpPWpGaD
Etoposide—ABCC10—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.5e-05	0.00208	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	5.42e-05	0.00205	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	5.38e-05	0.00204	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	5.22e-05	0.00198	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	4.98e-05	0.00189	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	4.9e-05	0.00185	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	4.89e-05	0.00185	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—GPX1—dilated cardiomyopathy	4.84e-05	0.00183	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.74e-05	0.00179	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	4.72e-05	0.00179	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—CD36—dilated cardiomyopathy	4.71e-05	0.00178	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	4.7e-05	0.00178	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	4.6e-05	0.00174	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.5e-05	0.0017	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.46e-05	0.00169	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	4.42e-05	0.00167	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.34e-05	0.00164	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.31e-05	0.00163	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.25e-05	0.00161	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—AGT—dilated cardiomyopathy	4.24e-05	0.00161	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.16e-05	0.00157	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	4.16e-05	0.00157	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.02e-05	0.00152	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	3.99e-05	0.00151	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.96e-05	0.0015	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.91e-05	0.00148	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.91e-05	0.00148	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	3.73e-05	0.00141	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.68e-05	0.00139	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.64e-05	0.00138	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.58e-05	0.00136	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	3.51e-05	0.00133	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	3.51e-05	0.00133	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	3.5e-05	0.00133	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	3.42e-05	0.00129	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	3.42e-05	0.00129	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	3.42e-05	0.00129	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	3.3e-05	0.00125	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	3.29e-05	0.00125	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.25e-05	0.00123	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.25e-05	0.00123	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.23e-05	0.00122	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.19e-05	0.00121	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	3.17e-05	0.0012	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.07e-05	0.00116	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	3.03e-05	0.00115	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.01e-05	0.00114	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	2.98e-05	0.00113	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	2.98e-05	0.00113	CbGpPWpGaD
Etoposide—ABCC1—Disease—NPPA—dilated cardiomyopathy	2.89e-05	0.00109	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.88e-05	0.00109	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	2.85e-05	0.00108	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	2.84e-05	0.00108	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.82e-05	0.00107	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.81e-05	0.00106	CbGpPWpGaD
Etoposide—ABCC1—Disease—PSEN2—dilated cardiomyopathy	2.8e-05	0.00106	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	2.71e-05	0.00102	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GPX1—dilated cardiomyopathy	2.65e-05	0.001	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	2.64e-05	0.001	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	2.64e-05	0.001	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—CD36—dilated cardiomyopathy	2.58e-05	0.000977	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	2.58e-05	0.000976	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.53e-05	0.000956	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.49e-05	0.00094	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.44e-05	0.000922	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.37e-05	0.000898	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AGT—dilated cardiomyopathy	2.32e-05	0.00088	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.25e-05	0.000851	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.14e-05	0.000808	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.13e-05	0.000805	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.11e-05	0.000799	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2e-05	0.000756	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.98e-05	0.000751	CbGpPWpGaD
Etoposide—PTGS2—Disease—NPPA—dilated cardiomyopathy	1.94e-05	0.000733	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.93e-05	0.000732	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.93e-05	0.000731	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.88e-05	0.000713	CbGpPWpGaD
Etoposide—PTGS2—Disease—PSEN2—dilated cardiomyopathy	1.88e-05	0.00071	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.84e-05	0.000697	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.79e-05	0.000679	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.7e-05	0.000642	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.69e-05	0.000638	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.67e-05	0.000631	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	1.64e-05	0.00062	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.63e-05	0.000616	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CD36—dilated cardiomyopathy	1.6e-05	0.000604	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.57e-05	0.000595	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.53e-05	0.00058	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.53e-05	0.000579	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.47e-05	0.000555	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AGT—dilated cardiomyopathy	1.44e-05	0.000543	CbGpPWpGaD
Etoposide—ABCC1—Disease—RAC1—dilated cardiomyopathy	1.41e-05	0.000532	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.38e-05	0.000524	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.38e-05	0.000522	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.37e-05	0.000518	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	1.33e-05	0.000504	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.3e-05	0.000494	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	0.00049	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	1.28e-05	0.000486	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CD36—dilated cardiomyopathy	1.25e-05	0.000473	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.000442	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.13e-05	0.000427	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AGT—dilated cardiomyopathy	1.13e-05	0.000426	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.1e-05	0.000416	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.09e-05	0.000414	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	1.09e-05	0.000411	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.07e-05	0.000403	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CD36—dilated cardiomyopathy	1.06e-05	0.0004	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AGT—dilated cardiomyopathy	9.9e-06	0.000375	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.6e-06	0.000363	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AGT—dilated cardiomyopathy	9.51e-06	0.00036	CbGpPWpGaD
Etoposide—PTGS2—Disease—RAC1—dilated cardiomyopathy	9.44e-06	0.000357	CbGpPWpGaD
Etoposide—ABCC1—Disease—RAF1—dilated cardiomyopathy	9.33e-06	0.000353	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	8.61e-06	0.000326	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CD36—dilated cardiomyopathy	8.39e-06	0.000317	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	8.11e-06	0.000307	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	8.09e-06	0.000306	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.93e-06	0.0003	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	7.9e-06	0.000299	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	7.88e-06	0.000298	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AGT—dilated cardiomyopathy	7.55e-06	0.000286	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	7.11e-06	0.000269	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	7.1e-06	0.000268	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	7.01e-06	0.000265	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	6.83e-06	0.000258	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—dilated cardiomyopathy	6.4e-06	0.000242	CbGpPWpGaD
Etoposide—PTGS2—Disease—RAF1—dilated cardiomyopathy	6.26e-06	0.000237	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	6.15e-06	0.000233	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	6.11e-06	0.000231	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CD36—dilated cardiomyopathy	5.95e-06	0.000225	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AGT—dilated cardiomyopathy	5.35e-06	0.000203	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.87e-06	0.000184	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.75e-06	0.00018	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—dilated cardiomyopathy	4.29e-06	0.000162	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	4.27e-06	0.000162	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.76e-06	0.000142	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.66e-06	0.000139	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.3e-06	0.000125	CbGpPWpGaD
